Bayer braces for Q3 surge in Roundup claims

Oct. 16, 2019 10:44 AM ETBayer Aktiengesellschaft (BAYRY)By: Carl Surran, SA News Editor7 Comments
  • Bayer (OTCPK:BAYRY -0.3%) says it expects a "significant surge" in the number of plaintiffs suing the company over its Roundup weedkiller when it reports earnings later this month.
  • The company thinks an increase in advertising by U.S. attorneys seeking new clients since mediation talks began likely will add to the litigation, but also says "the number of plaintiffs is not an indication of the merits of these cases."
  • J.P. Morgan analysts recently said the current number of plaintiffs could exceed 45K, compared with Bayer's last estimate of 18,400 in July.
  • The Roundup crisis already has cost Bayer more than $30B in market value as the company lost three U.S. trials over whether the herbicide causes cancer.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.